 |
市場調查報告書
商品編碼
1597166
北美臨床參考實驗室市場預測至 2031 年 - 區域分析 - 按服務提供者（醫院、獨立和診所）和應用（實驗室醫學、臨床試驗等）North America Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others) |
||||||
2023年北美臨床參考實驗室市值為175.7005億美元，預計到2031年將達到291.0442億美元；預計2023年至2031年複合年成長率為6.5%。
慢性病和傳染病的上升推動了北美臨床參考實驗室市場
慢性病盛行率的不斷上升以及各種傳染病的出現和爆發刺激了對新治療方案和更新治療類別的需求，並在現有治療類別中產生了對更好治療方案的需求。根據世界衛生組織2023年9月發布的資料，包括心臟病、癌症、中風、糖尿病和慢性肺病在內的非傳染性疾病（NCD）每年導致4,100萬人死亡。據聯合健康基金會稱，到 2022 年，超過 2900 萬美國成年人報告患有三種或以上慢性病。臨床參考實驗室在現代醫療保健中發揮著重要作用。參考實驗室為需要專門實驗室檢測設備和專業知識的傳染病（例如豬流感、甲型和B型肝炎）提供快速診斷服務。 。在 COVID-19 大流行期間，很明顯，醫學參考實驗室對於快速測試、建立新技術、生成和分析資料以及作為知識中心至關重要。參考實驗室不僅僅是大容量測試設施；它們是專業知識和資料的中心。因此，傳染病和慢性病的盛行率上升正在推動臨床參考實驗室市場的成長。
北美臨床參考實驗室市場概況
美國是領先的臨床研究目的地之一。近一半的臨床試驗是在美國進行的。此外，由於核准時間短、監管框架有利以及醫療基礎設施完善，大多數製藥研究公司選擇在美國進行臨床試驗。此外，美國臨床試驗產生的資料已被全球接受。根據世界衛生組織（WHO）2021年報告，美國登記的臨床試驗數量最多（157,618項）。
下表顯示了在美國註冊的臨床試驗數量、招募的患者總數以及美國在全球給定參數中所佔的百分比。
2023年
註冊臨床試驗研究
研究中招募的患者
我們
139,632（全球研究的 31%）
20,680 名（佔全球員工總數的 32%）
資料來源：ClinicalTrial.gov 報告
透過併購擴大公司准入進一步推動了美國臨床參考實驗室市場的成長。例如，2020年12月，美國私人臨床檢測實驗室臨床參考實驗室（CRL）收購了領先的綜合篩檢工具和解決方案供應商Confirm BioSciences。確認將繼續以目前的名稱作為子公司。此次收購擴大了Confirm獲得實驗室測試服務和研發能力的機會。 NCEZID 實驗室、梅奧診所實驗室和 CRL 是領先的臨床試驗參考實驗室之一。美國臨床試驗數量的不斷增加有利於該國臨床參考實驗室市場的成長。
北美臨床參考實驗室市場收入及 2031 年預測（百萬美元）
北美臨床參考實驗室市場細分
北美臨床參考實驗室市場按服務提供者、應用程式和國家分類。
根據服務供應商，北美臨床參考實驗室市場分為醫院型、獨立型和診所型。 2023 年，醫院細分市場佔據最大的市場佔有率。
從應用來看，北美臨床參考實驗室市場分為檢驗醫學、臨床試驗等。 2023 年，檢驗醫學領域佔據最大的市場佔有率。
依國家/地區分類，北美臨床參考實驗室市場分為美國、加拿大和墨西哥。 2023 年，美國主導北美臨床參考實驗室市佔率。
Sonic Healthcare Ltd、Laboratory Corp of America Holdings、Quest Diagnostics Inc、ARUP Laboratories Inc、Clinical Reference Laboratory Inc、SYNLAB International GmbH、Myraid Genetics Inc、Boca Biolistics LLC 和 TOPLAB 是北美臨床參考領域的一些領先公司實驗室市場。
目錄
第 1 章：簡介
第 2 章：執行摘要
- 北美主要見解
第 3 章：研究方法
- 覆蓋範圍
- 二次研究
- 初步研究
第 4 章：北美臨床參考實驗室市場 - 主要市場動態
- 市場促進因素
- 慢性病和傳染病的盛行率上升
- 臨床試驗數量不斷增加
- 市場限制
- 與規範架構和採用持續技術發展相關的複雜性
- 市場機會
- 與參考實驗室的策略舉措
- 未來趨勢
- 人工智慧在臨床參考實驗室的應用
- 促進因素和限制的影響：
第 5 章：臨床參考實驗室市場 - 北美分析
- 臨床參考實驗室市場收入，2021-2031
- 臨床參考市場預測與分析
第 6 章：北美臨床參考實驗室市場分析 - 按服務提供者
- 概述
- 以醫院為基礎
- 獨立式
- 基於臨床
第 7 章：北美臨床參考實驗室市場分析 - 按應用
- 概述
- 檢驗醫學
- 臨床試驗
- 其他
第 8 章：北美臨床參考實驗室市場 - 國家分析
- 北美洲
- 美國
- 加拿大
- 墨西哥
第 9 章：臨床參考實驗室市場-產業格局
- 概述
- 臨床參考實驗室市場的成長策略
- 無機成長策略
- 概述
- 有機成長策略
- 概述
第 10 章：公司簡介
- Sonic Healthcare Ltd
- Laboratory Corp of America Holdings
- Quest Diagnostics Inc
- ARUP Laboratories Inc
- Clinical Reference Laboratory Inc
- SYNLAB International GmbH
- Myraid Genetics Inc
- Boca Biolistics LLC
- TOPLAB
第 11 章：附錄
The North America clinical reference laboratory market was valued at US$ 17,570.05 million in 2023 and is expected to reach US$ 29,104.42 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031.
Rising Prevalence of Chronic and Infectious Diseases Fuels North America Clinical Reference Laboratory Market
The increasing prevalence of chronic diseases and the emergence and outbreak of various infectious diseases have fueled the demand for novel treatment options and newer therapeutic categories and created the need for better treatment options in existing therapeutic categories. According to the WHO data released in September 2023, noncommunicable diseases (NCDs), including heart disease, cancer, stroke, diabetes, and chronic lung disease, kill 41 million people each year. According to the United Health Foundation, more than 29 million US adults reported having three or more chronic conditions in 2022. Accurate diagnostics are critical for identifying disease biomarkers and detecting organisms, particularly in cancer and tuberculosis. Clinical reference laboratories play an important role in modern healthcare. The reference laboratories provide services for the quick diagnosis of infectious diseases that require specialized laboratory testing equipment and expertise, such as swine flu, hepatitis A and B. These laboratories also offer low-cost diagnostic testing for common chronic conditions such as cancer, diabetes, and cardiovascular disease. During the COVID-19 pandemic, it became evident that medical reference labs are critical for rapid testing, establishing novel techniques, generating and analyzing data, and serving as knowledge hubs. Reference labs are more than just high-volume testing facilities; they are the hubs of expertise and data. Thus, the rising prevalence of infectious and chronic diseases is driving the growth of the clinical reference laboratory market.
North America Clinical Reference Laboratory Market Overview
The US is one of the leading clinical research destinations. Nearly half of the total clinical trials are performed in the US. Additionally, most pharmaceutical research companies choose to perform clinical trials in the US owing to fast approval timelines, a favorable regulatory framework, and established medical infrastructure. Moreover, data generated for clinical trials in the US is accepted globally. According to the World Health Organization (WHO) report in 2021, the US registered the highest number of clinical trials (157,618).
The expanding access of companies through mergers and acquisitions further boosts the growth of the clinical reference laboratory market in the US. For instance, in December 2020, Clinical Reference Laboratory (CRL)-a privately held clinical testing laboratory in the US-acquired Confirm BioSciences, a leading provider of comprehensive screening tools and solutions. Confirm will continue as a subsidiary under its current name. The acquisition expands Confirm's access to lab testing services and R&D capabilities. NCEZID laboratories, Mayo Clinic Laboratories, and CRL are among the leading reference laboratories for clinical trials. The growing number of clinical trials in the US favors the growth of the clinical reference laboratory market in the country.
North America Clinical Reference Laboratory Market Segmentation
The North America clinical reference laboratory market is categorized into service provider, application, and country.
Based on service provider, the North America clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.
In terms of application, the North America clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.
By country, the North America clinical reference laboratory market is segmented into the US, Canada, and Mexico. The US dominated the North America clinical reference laboratory market share in 2023.
Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, ARUP Laboratories Inc, Clinical Reference Laboratory Inc, SYNLAB International GmbH, Myraid Genetics Inc, Boca Biolistics LLC, and TOPLAB are some of the leading companies operating in the North America clinical reference laboratory market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 North America Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Clinical Reference Laboratory Market - Key Market Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Prevalence of Chronic and Infectious Diseases
- 4.1.2 Increasing Number of Clinical Trials
- 4.2 Market Restraints
- 4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
- 4.3 Market Opportunities
- 4.3.1 Strategic Initiatives with Reference Laboratories
- 4.4 Future Trends
- 4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
- 4.5 Impact of Drivers and Restraints:
5. Clinical Reference Laboratory Market - North America Analysis
- 5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
- 5.2 Clinical Reference Market Forecast and Analysis
6. North America Clinical Reference Laboratory Market Analysis - by Service Provider
- 6.1 Overview
- 6.2 Hospital-Based
- 6.2.1 Overview
- 6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 6.3 Standalone
- 6.3.1 Overview
- 6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 6.4 Clinical Based
- 6.4.1 Overview
- 6.4.2 Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
7. North America Clinical Reference Laboratory Market Analysis - by Application
- 7.1 Overview
- 7.2 Laboratory Medicine
- 7.2.1 Overview
- 7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Clinical Trials
- 7.3.1 Overview
- 7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Clinical Reference Laboratory Market - Country Analysis
- 8.1 North America
- 8.1.1 North America: Clinical Reference Laboratory Market Breakdown, by Key Country, 2023 and 2031 (%)
- 8.1.1.1 US: Clinical Reference Laboratory Market - Overview
- 8.1.1.2 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.2.1 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million), by Service Provider
- 8.1.1.2.2 US: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
- 8.1.1.3 Canada: Clinical Reference Laboratory Market - Overview
- 8.1.1.4 Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.4.1 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
- 8.1.1.4.2 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
- 8.1.1.5 Mexico: Clinical Reference Laboratory Market - Overview
- 8.1.1.6 Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.6.1 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
- 8.1.1.6.2 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
- 8.1.1 North America: Clinical Reference Laboratory Market Breakdown, by Key Country, 2023 and 2031 (%)
9. Clinical Reference Laboratory Market-Industry Landscape
- 9.1 Overview
- 9.2 Growth Strategies in the Clinical Reference Laboratory Market
- 9.3 Inorganic Growth Strategies
- 9.3.1 Overview
- 9.4 Organic Growth Strategies
- 9.4.1 Overview
10. Company Profiles
- 10.1 Sonic Healthcare Ltd
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
- 10.2 Laboratory Corp of America Holdings
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
- 10.3 Quest Diagnostics Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
- 10.4 ARUP Laboratories Inc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
- 10.5 Clinical Reference Laboratory Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
- 10.6 SYNLAB International GmbH
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
- 10.7 Myraid Genetics Inc
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
- 10.8 Boca Biolistics LLC
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
- 10.9 TOPLAB
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
11. Appendix
- 11.1 About The Insight Partners
- 11.2 Glossary of Terms
List Of Tables
- Table 1. North America Clinical Reference Laboratory Market Segmentation
- Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
- Table 3. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
- Table 4. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
- Table 5. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
- Table 6. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
- Table 7. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
- Table 8. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
- Table 9. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
- Table 10. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
- Table 11. Glossary of Terms
List Of Figures
- Figure 1. North America Clinical Reference Laboratory Market Segmentation, by Country
- Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
- Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
- Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 8. Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
- Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 13. North America: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
- Figure 14. North America: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
- Figure 15. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 16. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 17. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 18. Growth Strategies in the Clinical Reference Laboratory Market
